New brain aneurysm device gets first human test

NCT ID NCT07259018

Not yet recruiting Disease control Sponsor: LuSeed Vascular LTD. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early study will test a new device called the LuSeed Aneurysm Embolization System in 10 people with unruptured brain aneurysms. The device is designed to block blood flow to the aneurysm, reducing the risk of rupture. The main goals are to see if the device is safe and can be placed correctly during a minimally invasive procedure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: LuSeed Aneurysm Embolization System (a device implanted via catheter to block blood flow to the aneurysm)
What this could lead to: If successful, this could provide a new, less invasive treatment option for people with unruptured brain aneurysms.
What could go wrong: This is a very early, small study (10 people) focused only on safety and whether the device can be placed correctly. It is not designed to prove the device works long-term, and there are risks like stroke or death.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANEURYSM CEREBRAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Aneurysm brain aneurysm intracranial berry aneurysm pili bifurcati

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANEURYSM CEREBRAL BIFURCATION BRAIN ANEURYSM SACCULAR ANEURYSM UNRUPTURED INTRACRANIAL ANEURYSM

Contacts and locations

Locations

St. Michael's Hospital - Unity Health Toronto

Toronto, Ontario, M5C 1R6, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.